What starts with nonspecific symptoms like persistent fatigue, sore throat, and swollen lymph nodes—can lead to lifelong impacts on health.
For many students, these symptoms are easy to attribute to stress, poor sleep, or a demanding schedule. When they persist for weeks rather than days, the underlying cause can be Infectious Mononucleosis, commonly referred to as mono.
Mono is most commonly caused by the Epstein–Barr virus, a highly prevalent virus that infects over 90 per cent of people worldwide. Infection in childhood is typically mild or asymptomatic. In adolescents and young adults—particularly university students—EBV infection is more likely to result in symptomatic mono. Close contact, shared living spaces, and frequent social interaction increase the likelihood of transmission on campus.
In many cases, mono’s self-limiting. Symptoms such as fever, sore throat, and lymph node swelling usually resolve within several weeks. Fatigue, however, often lasts longer and can persist for weeks or months after other symptoms improve. This prolonged fatigue distinguishes mono from many other common viral infections.
Although the acute illness resolves, EBV remains latent in the body for life. A growing body of research indicates that prior EBV infection is associated with an increased risk of certain chronic conditions.
One of the most well-established associations is between EBV and Multiple Sclerosis (MS). Studies have shown that most of those diagnosed with MS have evidence of prior EBV infection, and that the risk of developing MS increases following symptomatic mono. Current research suggests EBV may contribute to immune system dysregulation, which plays a role in autoimmune disease, although the exact biological mechanisms are still unknown.
EBV has also been studied in relation to other autoimmune conditions, including systemic lupus erythematosus, as well as certain cancers such as Hodgkin lymphoma and Nasopharyngeal Carcinoma. These outcomes are uncommon, but their association with EBV has made the virus a focus of long-term research.
For students, the more immediate impact of mono can still be limiting. The illness can interfere with academic performance, employment, and daily activities, especially because recovery timelines vary and fatigue may persist. There’s no specific antiviral treatment for uncomplicated mono. Management consists of rest, hydration, and symptomatic care. Students are also advised to avoid contact sports for several weeks due to the risk of splenic enlargement and rupture.
Most people who contract mono recover fully and don’t experience long-term complications. However, evidence linking EBV to various chronic conditions complicates the idea that mono is always a minor or inconsequential illness.
Tags
medicine, mono, Student health
All final editorial decisions are made by the Editor(s) in Chief and/or the Managing Editor. Authors should not be contacted, targeted, or harassed under any circumstances. If you have any grievances with this article, please direct your comments to journal_editors@ams.queensu.ca.
